PMD - サイケメディクス （Psychemedics Corporation） サイケメディクスPMDのチャート
PMDの企業情報
| symbol | PMD |
|---|---|
| 会社名 | Psychemedics Corp. （サイケメディクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical Specialities |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | 事業概要 サイケメディクス(Psychemedics Corporation)は毛髪試料の分析を通じて乱用物質の検出を目的とする試験サービスを提供する。同社の試験方法は技術を利用して毛髪試料を酵素的に溶解し、質量分析による確認試験とともに、放射免疫測定を行う。同社の技術の主なアプリケーションは試験サービスとして、特定乱用薬物の存在を認定するために毛髪試料の分析を行うことである。同社の試験は摂取された薬物の近似量を表明できる定量的情報、並びに長期間にわたる各々の薬物利用パターンを表明できる過去のデータを提供し、ほかのタイプの薬物検査より優れた検出能力を有する。同社は産業慣例に従って、質量分析を通じてコカイン、マリファナ、フェンシクリジン（PCP）、メタンフェタミンとアヘンの商用試験・確認サービスを提供する。 サイケメディクスは、米国の薬物検査会社。毛髪を検体とした違法薬物検査サ―ビスを提供する。毛髪での麻薬検査は90日まで遡った麻薬使用を検知でき、尿や唾液よりも正確な検査結果を出すことが可能。また、毛髪による飲酒検査も行う。本社は、マサチュ―セッツ州アクトン。 Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on company's unique patented drug testing process. Psychemedics Corporation strongly believes its drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods. |
| 本社所在地 | 289 Great Road Acton MA 01720 USA |
| 代表者氏名 | Raymond C. Kubacki レイモンド・C・クバッキー |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 800-628-8073 |
| 設立年月日 | 31656 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 231人 |
| url | www.psychemedics.com |
| nasdaq_url | https://www.nasdaq.com/symbol/pmd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 11.09400 |
| 終値（lastsale） | 18.6412 |
| 時価総額（marketcap） | 102661972.3944 |
| 時価総額 | 時価総額（百万ドル） 100.56260 |
| 売上高 | 売上高（百万ドル） 41.53000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 95.74060 |
| 当期純利益 | 当期純利益（百万ドル） 7.34200 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Psychemedics Corp. revenues increased 9% to $21.7M. Net income increased 1% to $2.4M. Revenues reflect United States segment increase of 14% to $14.9M Other segment increase of 80% to $207K. Net income was partially offset by General_Administrative increase of 18% to $3.3M (expense) Research_development increase of 10% to $717K (expense). Dividend per share increased from $0.30 to $0.33. |
PMDのテクニカル分析
PMDのニュース
Psychemedics''s Ex-Dividend Date Is Wednesday, Here''s What You Need To Know 2023/05/19 14:46:09 Benzinga
Tuesday marks the last chance for investors to receive the next dividend payout from Psychemedics (NASDAQ: PMD ). What''s Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 7 cents per share. On Wednesday, Psychemedics will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will … Full story available on Benzinga.com
Psychemedics: Q1 Earnings Snapshot 2023/05/09 22:50:42 WTOP
ACTON, Mass. (AP) — ACTON, Mass. (AP) — Psychemedics Corp. (PMD) on Tuesday reported a loss of $384,000 in its…
Psychemedics GAAP EPS of -$0.07, revenue of $5.9M 2023/05/09 22:03:18 Seeking Alpha
Psychemedics press release (PMD): Q1 GAAP EPS of -$0.07.Revenue of $5.9M (-9.2% Y/Y).
Psychemedics Declares $0.07 Quarterly Dividend; 5.2% Yield 2023/05/09 21:37:01 Investing.com
https://www.investing.com/news/assorted/psychemedics-declares-007-quarterly-dividend-52-yield-432SI-3077859
Psychemedics''s Ex-Dividend Date Is Thursday, Here''s What You Need To Know 2023/03/27 14:45:46 Benzinga
Wednesday marks the last chance for investors to receive the next dividend payout from Psychemedics (NASDAQ: PMD ). What''s Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 7 cents per share. On Thursday, Psychemedics will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, … Full story available on Benzinga.com
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend 2022/08/09 21:15:00 GlobeNewswire
ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also announced a quarterly dividend of $0.07 per share payable to the shareholders of record as of August 24, 2022, to be paid on September 9, 2022.
Infineon and pmdtechnologies Develop 3D Depth-Sensing Technology for Magic Leap 2 2022/05/30 07:00:00 Kwhen Finance
Psychemedics raises dividend by 40% to $0.07 2022/05/10 21:57:25 Seeking Alpha
Psychemedics (PMD) declares $0.07/share quarterly dividend, 40% increase from prior dividend of $0.05.Forward yield 4.56%Payable June 24; for shareholders of record May 27; ex-div May…
Psychemedics GAAP EPS of $0.01, revenue of $6.5M 2022/05/10 21:48:37 Seeking Alpha
Psychemedics press release (PMD): Q1 GAAP EPS of $0.01.Revenue of $6.5M (+14.0% Y/Y).
Psychemedics GAAP EPS of -$0.29, revenue of $6.44M 2022/03/29 21:24:00 Seeking Alpha
Psychemedics press release (NASDAQ:PMD): Q4 GAAP EPS of -$0.29.Revenue of $6.44M (+20.6% Y/Y).
Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results 2022/03/29 21:15:00 GlobeNewswire
ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2021.
Psychemedics (NASDAQ:PMD) Stock Price Passes Above 200-Day Moving Average of $0.00 2021/12/22 14:52:46 Dakota Financial News
Psychemedics Co. (NASDAQ:PMD) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $7.22. Psychemedics shares last traded at $7.22, with a volume of 5,375 shares traded. Separately, TheStreet upgraded shares of Psychemedics from a d+ rating to a []
Psychemedics Corporation Declares Cash Dividend 2021/12/10 22:00:00 Intrado Digital Media
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30 th , 2021 to shareholders of record as of December 20 th , 2021.